On 2025-08-06, Neumora Therapeutics, Inc. (NMRA) announced earnings per share of $-0.33 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-0.38.
The next expected annoucement date for quarterly earnings is 2025-11-11, with an average estimated earnings per share of $-0.34 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-06 | 2025-06-30 | $-0.38 | $-0.33 |
| 2025-05-12 | 2025-03-31 | $-0.40 | $-0.42 |
| 2025-03-03 | 2024-12-31 | $-0.46 | $-0.37 |
| 2024-11-12 | 2024-09-30 | $-0.38 | $-0.45 |
| 2024-08-06 | 2024-06-30 | $-0.37 | $-0.37 |
| 2024-05-07 | 2024-03-31 | $-0.35 | $-0.34 |
| 2024-03-07 | 2023-12-31 | $-0.65 | $-0.71 |
| 2023-11-01 | 2023-09-30 | $-0.48 | $-1.14 |